ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Gene Therapy CRO Services Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-35D16768
Home | Market Reports | Health| Nursing
Global Gene Therapy CRO Services Market Research Report 2024
BUY CHAPTERS

Global Gene Therapy CRO Services Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-35D16768
Report
November 2025
Pages:134
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
LabCorp
IQVIA Biotech
PPD
Medpace
Veristat
PAREXEL
Charles River Laboratories
Catalent Pharma Solutions
Premier Research
Catalent
Vial
Noble Life Sciences
Ergomed

Gene Therapy CRO Services Market

The global Gene Therapy CRO Services market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Gene therapy Contract Research Organization (CRO) services encompass a range of specialized offerings tailored to support the development and execution of preclinical and clinical research programs for gene therapy products. These services are designed to assist biopharmaceutical companies, academic institutions, and government agencies in advancing the development of gene therapy treatments for various diseases and medical conditions.
From a downstream perspective, SMBs accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Gene Therapy CRO Services leading manufacturers including Labcorp, IQVIA Biotech, PPD, Medpace, Veristat, Parexel, Charles River Laboratories, Catalent Pharma Solutions, Premier Research, Catalent, etc., dominate supply; the top five capture approximately % of global revenue, with Labcorp leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Gene Therapy CRO Services market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Gene Therapy CRO Services Market Report

Report Metric Details
Report Name Gene Therapy CRO Services Market
Segment by Type
  • Preclinical CRO
  • Clinical CRO
Segment by Application
  • SMBs
  • Large Companies
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Labcorp, IQVIA Biotech, PPD, Medpace, Veristat, Parexel, Charles River Laboratories, Catalent Pharma Solutions, Premier Research, Catalent, Vial, Noble Life Sciences, Ergomed
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Gene Therapy CRO Services study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
  • Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 14: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Gene Therapy CRO Services Market report?

Ans: The main players in the Gene Therapy CRO Services Market are Labcorp, IQVIA Biotech, PPD, Medpace, Veristat, Parexel, Charles River Laboratories, Catalent Pharma Solutions, Premier Research, Catalent, Vial, Noble Life Sciences, Ergomed

What are the Application segmentation covered in the Gene Therapy CRO Services Market report?

Ans: The Applications covered in the Gene Therapy CRO Services Market report are SMBs, Large Companies

What are the Type segmentation covered in the Gene Therapy CRO Services Market report?

Ans: The Types covered in the Gene Therapy CRO Services Market report are Preclinical CRO, Clinical CRO

1 Study Coverage
1.1 Introduction to Gene Therapy CRO Services: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Gene Therapy CRO Services Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Preclinical CRO
1.2.3 Clinical CRO
1.3 Market Segmentation by Application
1.3.1 Global Gene Therapy CRO Services Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 SMBs
1.3.3 Large Companies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Gene Therapy CRO Services Revenue Estimates and Forecasts 2020-2031
2.2 Global Gene Therapy CRO Services Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Gene Therapy CRO Services Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Gene Therapy CRO Services Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Preclinical CRO Market Size by Players
3.3.2 Clinical CRO Market Size by Players
3.4 Global Gene Therapy CRO Services Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Gene Therapy CRO Services Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Gene Therapy CRO Services Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Gene Therapy CRO Services Market Size by Type (2020-2031)
6.4 North America Gene Therapy CRO Services Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Gene Therapy CRO Services Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Gene Therapy CRO Services Market Size by Type (2020-2031)
7.4 Europe Gene Therapy CRO Services Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Gene Therapy CRO Services Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Gene Therapy CRO Services Market Size by Type (2020-2031)
8.4 Asia-Pacific Gene Therapy CRO Services Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Gene Therapy CRO Services Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Gene Therapy CRO Services Market Size by Type (2020-2031)
9.4 Central and South America Gene Therapy CRO Services Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Gene Therapy CRO Services Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Gene Therapy CRO Services Market Size by Type (2020-2031)
10.4 Middle East and Africa Gene Therapy CRO Services Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Gene Therapy CRO Services Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Labcorp
11.1.1 Labcorp Corporation Information
11.1.2 Labcorp Business Overview
11.1.3 Labcorp Gene Therapy CRO Services Product Features and Attributes
11.1.4 Labcorp Gene Therapy CRO Services Revenue and Gross Margin (2020-2025)
11.1.5 Labcorp Gene Therapy CRO Services Revenue by Product in 2024
11.1.6 Labcorp Gene Therapy CRO Services Revenue by Application in 2024
11.1.7 Labcorp Gene Therapy CRO Services Revenue by Geographic Area in 2024
11.1.8 Labcorp Gene Therapy CRO Services SWOT Analysis
11.1.9 Labcorp Recent Developments
11.2 IQVIA Biotech
11.2.1 IQVIA Biotech Corporation Information
11.2.2 IQVIA Biotech Business Overview
11.2.3 IQVIA Biotech Gene Therapy CRO Services Product Features and Attributes
11.2.4 IQVIA Biotech Gene Therapy CRO Services Revenue and Gross Margin (2020-2025)
11.2.5 IQVIA Biotech Gene Therapy CRO Services Revenue by Product in 2024
11.2.6 IQVIA Biotech Gene Therapy CRO Services Revenue by Application in 2024
11.2.7 IQVIA Biotech Gene Therapy CRO Services Revenue by Geographic Area in 2024
11.2.8 IQVIA Biotech Gene Therapy CRO Services SWOT Analysis
11.2.9 IQVIA Biotech Recent Developments
11.3 PPD
11.3.1 PPD Corporation Information
11.3.2 PPD Business Overview
11.3.3 PPD Gene Therapy CRO Services Product Features and Attributes
11.3.4 PPD Gene Therapy CRO Services Revenue and Gross Margin (2020-2025)
11.3.5 PPD Gene Therapy CRO Services Revenue by Product in 2024
11.3.6 PPD Gene Therapy CRO Services Revenue by Application in 2024
11.3.7 PPD Gene Therapy CRO Services Revenue by Geographic Area in 2024
11.3.8 PPD Gene Therapy CRO Services SWOT Analysis
11.3.9 PPD Recent Developments
11.4 Medpace
11.4.1 Medpace Corporation Information
11.4.2 Medpace Business Overview
11.4.3 Medpace Gene Therapy CRO Services Product Features and Attributes
11.4.4 Medpace Gene Therapy CRO Services Revenue and Gross Margin (2020-2025)
11.4.5 Medpace Gene Therapy CRO Services Revenue by Product in 2024
11.4.6 Medpace Gene Therapy CRO Services Revenue by Application in 2024
11.4.7 Medpace Gene Therapy CRO Services Revenue by Geographic Area in 2024
11.4.8 Medpace Gene Therapy CRO Services SWOT Analysis
11.4.9 Medpace Recent Developments
11.5 Veristat
11.5.1 Veristat Corporation Information
11.5.2 Veristat Business Overview
11.5.3 Veristat Gene Therapy CRO Services Product Features and Attributes
11.5.4 Veristat Gene Therapy CRO Services Revenue and Gross Margin (2020-2025)
11.5.5 Veristat Gene Therapy CRO Services Revenue by Product in 2024
11.5.6 Veristat Gene Therapy CRO Services Revenue by Application in 2024
11.5.7 Veristat Gene Therapy CRO Services Revenue by Geographic Area in 2024
11.5.8 Veristat Gene Therapy CRO Services SWOT Analysis
11.5.9 Veristat Recent Developments
11.6 Parexel
11.6.1 Parexel Corporation Information
11.6.2 Parexel Business Overview
11.6.3 Parexel Gene Therapy CRO Services Product Features and Attributes
11.6.4 Parexel Gene Therapy CRO Services Revenue and Gross Margin (2020-2025)
11.6.5 Parexel Recent Developments
11.7 Charles River Laboratories
11.7.1 Charles River Laboratories Corporation Information
11.7.2 Charles River Laboratories Business Overview
11.7.3 Charles River Laboratories Gene Therapy CRO Services Product Features and Attributes
11.7.4 Charles River Laboratories Gene Therapy CRO Services Revenue and Gross Margin (2020-2025)
11.7.5 Charles River Laboratories Recent Developments
11.8 Catalent Pharma Solutions
11.8.1 Catalent Pharma Solutions Corporation Information
11.8.2 Catalent Pharma Solutions Business Overview
11.8.3 Catalent Pharma Solutions Gene Therapy CRO Services Product Features and Attributes
11.8.4 Catalent Pharma Solutions Gene Therapy CRO Services Revenue and Gross Margin (2020-2025)
11.8.5 Catalent Pharma Solutions Recent Developments
11.9 Premier Research
11.9.1 Premier Research Corporation Information
11.9.2 Premier Research Business Overview
11.9.3 Premier Research Gene Therapy CRO Services Product Features and Attributes
11.9.4 Premier Research Gene Therapy CRO Services Revenue and Gross Margin (2020-2025)
11.9.5 Premier Research Recent Developments
11.10 Catalent
11.10.1 Catalent Corporation Information
11.10.2 Catalent Business Overview
11.10.3 Catalent Gene Therapy CRO Services Product Features and Attributes
11.10.4 Catalent Gene Therapy CRO Services Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 Vial
11.11.1 Vial Corporation Information
11.11.2 Vial Business Overview
11.11.3 Vial Gene Therapy CRO Services Product Features and Attributes
11.11.4 Vial Gene Therapy CRO Services Revenue and Gross Margin (2020-2025)
11.11.5 Vial Recent Developments
11.12 Noble Life Sciences
11.12.1 Noble Life Sciences Corporation Information
11.12.2 Noble Life Sciences Business Overview
11.12.3 Noble Life Sciences Gene Therapy CRO Services Product Features and Attributes
11.12.4 Noble Life Sciences Gene Therapy CRO Services Revenue and Gross Margin (2020-2025)
11.12.5 Noble Life Sciences Recent Developments
11.13 Ergomed
11.13.1 Ergomed Corporation Information
11.13.2 Ergomed Business Overview
11.13.3 Ergomed Gene Therapy CRO Services Product Features and Attributes
11.13.4 Ergomed Gene Therapy CRO Services Revenue and Gross Margin (2020-2025)
11.13.5 Ergomed Recent Developments
12 Gene Therapy CRO ServicesIndustry Chain Analysis
12.1 Gene Therapy CRO Services Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Gene Therapy CRO Services Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Gene Therapy CRO Services Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
LabCorp
IQVIA Biotech
PPD
Medpace
Veristat
PAREXEL
Charles River Laboratories
Catalent Pharma Solutions
Premier Research
Catalent
Vial
Noble Life Sciences
Ergomed
List of Tables
 Table 1. Global Gene Therapy CRO Services Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Gene Therapy CRO Services Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Gene Therapy CRO Services Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Gene Therapy CRO Services Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Gene Therapy CRO Services Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 7. Global Gene Therapy CRO Services Revenue by Players (2020-2025) & (US$ Million)
 Table 8. Global Gene Therapy CRO Services Revenue Market Share by Players (2020-2025)
 Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 10. Global Gene Therapy CRO Services by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy CRO Services as of 2024)
 Table 11. Global Gene Therapy CRO Services Average Gross Margin (%) by Player (2020 VS 2024)
 Table 12. Global Gene Therapy CRO Services Companies Headquarters
 Table 13. Global Gene Therapy CRO Services Market Concentration Ratio (CR5 and HHI)
 Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 16. Global Gene Therapy CRO Services Revenue by Type (2020-2025) & (US$ Million)
 Table 17. Global Gene Therapy CRO Services Revenue by Type (2026-2031) & (US$ Million)
 Table 18. Key Product Attributes and Differentiation
 Table 19. Global Gene Therapy CRO Services Revenue by Application (2020-2025) & (US$ Million)
 Table 20. Global Gene Therapy CRO Services Revenue by Application (2026-2031) & (US$ Million)
 Table 21. Gene Therapy CRO Services High-Growth Sectors Demand CAGR (2024-2031)
 Table 22. Top Customers by Region
 Table 23. Top Customers by Application
 Table 24. North America Gene Therapy CRO Services Growth Accelerators and Market Barriers
 Table 25. North America Gene Therapy CRO Services Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 26. Europe Gene Therapy CRO Services Growth Accelerators and Market Barriers
 Table 27. Europe Gene Therapy CRO Services Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 28. Asia-Pacific Gene Therapy CRO Services Growth Accelerators and Market Barriers
 Table 29. Asia-Pacific Gene Therapy CRO Services Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 30. Central and South America Gene Therapy CRO Services Investment Opportunities and Key Challenges
 Table 31. Central and South America Gene Therapy CRO Services Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 32. Middle East and Africa Gene Therapy CRO Services Investment Opportunities and Key Challenges
 Table 33. Middle East and Africa Gene Therapy CRO Services Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 34. Labcorp Corporation Information
 Table 35. Labcorp Description and Major Businesses
 Table 36. Labcorp Product Features and Attributes
 Table 37. Labcorp Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 38. Labcorp Revenue Proportion by Product in 2024
 Table 39. Labcorp Revenue Proportion by Application in 2024
 Table 40. Labcorp Revenue Proportion by Geographic Area in 2024
 Table 41. Labcorp Gene Therapy CRO Services SWOT Analysis
 Table 42. Labcorp Recent Developments
 Table 43. IQVIA Biotech Corporation Information
 Table 44. IQVIA Biotech Description and Major Businesses
 Table 45. IQVIA Biotech Product Features and Attributes
 Table 46. IQVIA Biotech Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 47. IQVIA Biotech Revenue Proportion by Product in 2024
 Table 48. IQVIA Biotech Revenue Proportion by Application in 2024
 Table 49. IQVIA Biotech Revenue Proportion by Geographic Area in 2024
 Table 50. IQVIA Biotech Gene Therapy CRO Services SWOT Analysis
 Table 51. IQVIA Biotech Recent Developments
 Table 52. PPD Corporation Information
 Table 53. PPD Description and Major Businesses
 Table 54. PPD Product Features and Attributes
 Table 55. PPD Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 56. PPD Revenue Proportion by Product in 2024
 Table 57. PPD Revenue Proportion by Application in 2024
 Table 58. PPD Revenue Proportion by Geographic Area in 2024
 Table 59. PPD Gene Therapy CRO Services SWOT Analysis
 Table 60. PPD Recent Developments
 Table 61. Medpace Corporation Information
 Table 62. Medpace Description and Major Businesses
 Table 63. Medpace Product Features and Attributes
 Table 64. Medpace Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 65. Medpace Revenue Proportion by Product in 2024
 Table 66. Medpace Revenue Proportion by Application in 2024
 Table 67. Medpace Revenue Proportion by Geographic Area in 2024
 Table 68. Medpace Gene Therapy CRO Services SWOT Analysis
 Table 69. Medpace Recent Developments
 Table 70. Veristat Corporation Information
 Table 71. Veristat Description and Major Businesses
 Table 72. Veristat Product Features and Attributes
 Table 73. Veristat Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 74. Veristat Revenue Proportion by Product in 2024
 Table 75. Veristat Revenue Proportion by Application in 2024
 Table 76. Veristat Revenue Proportion by Geographic Area in 2024
 Table 77. Veristat Gene Therapy CRO Services SWOT Analysis
 Table 78. Veristat Recent Developments
 Table 79. Parexel Corporation Information
 Table 80. Parexel Description and Major Businesses
 Table 81. Parexel Product Features and Attributes
 Table 82. Parexel Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 83. Parexel Recent Developments
 Table 84. Charles River Laboratories Corporation Information
 Table 85. Charles River Laboratories Description and Major Businesses
 Table 86. Charles River Laboratories Product Features and Attributes
 Table 87. Charles River Laboratories Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 88. Charles River Laboratories Recent Developments
 Table 89. Catalent Pharma Solutions Corporation Information
 Table 90. Catalent Pharma Solutions Description and Major Businesses
 Table 91. Catalent Pharma Solutions Product Features and Attributes
 Table 92. Catalent Pharma Solutions Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 93. Catalent Pharma Solutions Recent Developments
 Table 94. Premier Research Corporation Information
 Table 95. Premier Research Description and Major Businesses
 Table 96. Premier Research Product Features and Attributes
 Table 97. Premier Research Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 98. Premier Research Recent Developments
 Table 99. Catalent Corporation Information
 Table 100. Catalent Description and Major Businesses
 Table 101. Catalent Product Features and Attributes
 Table 102. Catalent Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 103. Catalent Recent Developments
 Table 104. Vial Corporation Information
 Table 105. Vial Description and Major Businesses
 Table 106. Vial Product Features and Attributes
 Table 107. Vial Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 108. Vial Recent Developments
 Table 109. Noble Life Sciences Corporation Information
 Table 110. Noble Life Sciences Description and Major Businesses
 Table 111. Noble Life Sciences Product Features and Attributes
 Table 112. Noble Life Sciences Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 113. Noble Life Sciences Recent Developments
 Table 114. Ergomed Corporation Information
 Table 115. Ergomed Description and Major Businesses
 Table 116. Ergomed Product Features and Attributes
 Table 117. Ergomed Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 118. Ergomed Recent Developments
 Table 119. Raw Materials Key Suppliers
 Table 120. Distributors List
 Table 121. Market Trends and Market Evolution
 Table 122. Market Drivers and Opportunities
 Table 123. Market Challenges, Risks, and Restraints
 Table 124. Research Programs/Design for This Report
 Table 125. Key Data Information from Secondary Sources
 Table 126. Key Data Information from Primary Sources


List of Figures
 Figure 1. Gene Therapy CRO Services Product Picture
 Figure 2. Global Gene Therapy CRO Services Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Preclinical CRO Product Picture
 Figure 4. Clinical CRO Product Picture
 Figure 5. Global Gene Therapy CRO Services Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 6. SMBs
 Figure 7. Large Companies
 Figure 8. Gene Therapy CRO Services Report Years Considered
 Figure 9. Global Gene Therapy CRO Services Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 10. Global Gene Therapy CRO Services Revenue (2020-2031) & (US$ Million)
 Figure 11. Global Gene Therapy CRO Services Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 12. Global Gene Therapy CRO Services Revenue Market Share by Region (2020-2031)
 Figure 13. Global Gene Therapy CRO Services Revenue Market Share Ranking (2024)
 Figure 14. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 15. Preclinical CRO Revenue Market Share by Player in 2024
 Figure 16. Clinical CRO Revenue Market Share by Player in 2024
 Figure 17. Global Gene Therapy CRO Services Revenue Market Share by Type (2020-2031)
 Figure 18. Global Gene Therapy CRO Services Revenue Market Share by Application (2020-2031)
 Figure 19. North America Gene Therapy CRO Services Revenue YoY (2020-2031) & (US$ Million)
 Figure 20. North America Top 5 Players Gene Therapy CRO Services Revenue (US$ Million) in 2024
 Figure 21. North America Gene Therapy CRO Services Revenue (US$ Million) by Type (2020 - 2031)
 Figure 22. North America Gene Therapy CRO Services Revenue (US$ Million) by Application (2020-2031)
 Figure 23. US Gene Therapy CRO Services Revenue (2020-2031) & (US$ Million)
 Figure 24. Canada Gene Therapy CRO Services Revenue (2020-2031) & (US$ Million)
 Figure 25. Mexico Gene Therapy CRO Services Revenue (2020-2031) & (US$ Million)
 Figure 26. Europe Gene Therapy CRO Services Revenue YoY (2020-2031) & (US$ Million)
 Figure 27. Europe Top 5 Players Gene Therapy CRO Services Revenue (US$ Million) in 2024
 Figure 28. Europe Gene Therapy CRO Services Revenue (US$ Million) by Type (2020-2031)
 Figure 29. Europe Gene Therapy CRO Services Revenue (US$ Million) by Application (2020-2031)
 Figure 30. Germany Gene Therapy CRO Services Revenue (2020-2031) & (US$ Million)
 Figure 31. France Gene Therapy CRO Services Revenue (2020-2031) & (US$ Million)
 Figure 32. U.K. Gene Therapy CRO Services Revenue (2020-2031) & (US$ Million)
 Figure 33. Italy Gene Therapy CRO Services Revenue (2020-2031) & (US$ Million)
 Figure 34. Russia Gene Therapy CRO Services Revenue (2020-2031) & (US$ Million)
 Figure 35. Asia-Pacific Gene Therapy CRO Services Revenue YoY (2020-2031) & (US$ Million)
 Figure 36. Asia-Pacific Top 8 Players Gene Therapy CRO Services Revenue (US$ Million) in 2024
 Figure 37. Asia-Pacific Gene Therapy CRO Services Revenue (US$ Million) by Type (2020-2031)
 Figure 38. Asia-Pacific Gene Therapy CRO Services Revenue (US$ Million) by Application (2020-2031)
 Figure 39. Indonesia Gene Therapy CRO Services Revenue (2020-2031) & (US$ Million)
 Figure 40. Japan Gene Therapy CRO Services Revenue (2020-2031) & (US$ Million)
 Figure 41. South Korea Gene Therapy CRO Services Revenue (2020-2031) & (US$ Million)
 Figure 42. Australia Gene Therapy CRO Services Revenue (2020-2031) & (US$ Million)
 Figure 43. India Gene Therapy CRO Services Revenue (2020-2031) & (US$ Million)
 Figure 44. Indonesia Gene Therapy CRO Services Revenue (2020-2031) & (US$ Million)
 Figure 45. Vietnam Gene Therapy CRO Services Revenue (2020-2031) & (US$ Million)
 Figure 46. Malaysia Gene Therapy CRO Services Revenue (2020-2031) & (US$ Million)
 Figure 47. Philippines Gene Therapy CRO Services Revenue (2020-2031) & (US$ Million)
 Figure 48. Singapore Gene Therapy CRO Services Revenue (2020-2031) & (US$ Million)
 Figure 49. Central and South America Gene Therapy CRO Services Revenue YoY (2020-2031) & (US$ Million)
 Figure 50. Central and South America Top 5 Players Gene Therapy CRO Services Revenue (US$ Million) in 2024
 Figure 51. Central and South America Gene Therapy CRO Services Revenue (US$ Million) by Type (2020-2031)
 Figure 52. Central and South America Gene Therapy CRO Services Revenue (US$ Million) by Application (2020-2031)
 Figure 53. Brazil Gene Therapy CRO Services Revenue (2020-2025) & (US$ Million)
 Figure 54. Argentina Gene Therapy CRO Services Revenue (2020-2025) & (US$ Million)
 Figure 55. Middle East and Africa Gene Therapy CRO Services Revenue YoY (2020-2031) & (US$ Million)
 Figure 56. Middle East and Africa Top 5 Players Gene Therapy CRO Services Revenue (US$ Million) in 2024
 Figure 57. South America Gene Therapy CRO Services Revenue (US$ Million) by Type (2020-2031)
 Figure 58. Middle East and Africa Gene Therapy CRO Services Revenue (US$ Million) by Application (2020-2031)
 Figure 59. GCC Countries Gene Therapy CRO Services Revenue (2020-2025) & (US$ Million)
 Figure 60. Israel Gene Therapy CRO Services Revenue (2020-2025) & (US$ Million)
 Figure 61. Egypt Gene Therapy CRO Services Revenue (2020-2025) & (US$ Million)
 Figure 62. South Africa Gene Therapy CRO Services Revenue (2020-2025) & (US$ Million)
 Figure 63. Gene Therapy CRO Services Industry Chain Mapping
 Figure 64. Channels of Distribution (Direct Vs Distribution)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

Global Cell and Gene Therapy CRO Market Research Report 2024
Global CRO Services Market Research Report 2024
Global Contract Research Organization Solution Market Research Report 2025
Global Clinical Contract Research Organization Services Market Research Report 2024
Contract Research Organizations Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Contract Research Organisations CROs Market Research Report 2024
Global Contract Research Organization CRO Services Market Insights Forecast to 2030
Healthcare Contract Research Organizations CRO Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global CRO Services for BioPharma Market Research Report 2024
Global Healthcare Contract Research Organization Market Insights Forecast to 2030
CROs Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pharmaceutical CRO Services Market Research Report 2024
Global The Contract Research CRO Market Insights Forecast to 2030
Global Clinical and Non clinical Contract Research Organization Services Market Research Report 2024
Clinical CRO Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Full Service CRO Market Research Report 2024
Global Preclinical Contract Research Organization CRO Market Research Report 2025
Global Healthcare CRO Market Insights Forecast to 2030
Global Preclinical CRO Treatment Market Insights Forecast to 2030
Global CRO in Clinical Trials Market Research Report 2024

RELATED REPORTS

Global Life Sciences IT Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-19E17259
Wed Nov 12 00:00:00 UTC 2025

Add to Cart

Global Rehabilitation Evaluation Equipment Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-39U17029
Wed Nov 12 00:00:00 UTC 2025

Add to Cart

Global Modular Healthcare Buildings Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-24Y16719
Wed Nov 12 00:00:00 UTC 2025

Add to Cart

Global Digital Telepathology Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-0S20450
Wed Nov 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions